Skip to Content
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 10/10/18

Leukemia SPOREs

Despite the fact that major advances in diagnosis and treatment were achieved in the last 50 years, especially in childhood leukemia, this group of diseases remains a very serious medical problem. According to the Surveillance, Epidemiology and End Results (SEER) Program data, it is estimated that in 2016 there will be a total of 60,140 new cases of leukemia in the U.S. (3.6% of all new cancer cases) and that 24,400 people will die of this disease. In 2013 there were an estimated 333,975 people living with, or in remission from, leukemia in the U.S. Leukemia takes a particularly heavy toll on younger Americans as it causes one-third of all cancer deaths in children and adolescents younger than 15 years. Over the last 20 years the incidence of this cancer has held steady while the death rate has only decreased very slightly. The first round of SPORE applications in leukemia took place in 2002, with the subsequent award of the first Leukemia SPORE in 2003.